Comparison of Multiparametric Prostate MRI and Ga-68 PSMA PET Imaging in Prostate Cancer Staging
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Prostate Cancer
- Sponsor
- Gulhane Training and Research Hospital
- Enrollment
- 47
- Locations
- 1
- Primary Endpoint
- Lesion location
- Last Updated
- 3 years ago
Overview
Brief Summary
In this study, it is aimed to compare the lesion location, lesion size, local and distant metastases detection rates of Ga68 PSMA PET and Multiparametric Prostate MR imaging tests used in staging in patients diagnosed with prostate cancer.
The pathologies of the patients who were decided to undergo radical prostatectomy as a treatment will also be compared with the staging tests.
Investigators
Can Sicimli
Principal Investigator
Gulhane Training and Research Hospital
Eligibility Criteria
Inclusion Criteria
- •diagnosed with prostate cancer
- •Gleason score 7 or above / 6 with high risk
- •No other treatment
Exclusion Criteria
- •treated with radiotherapy
- •treated with ADT
Outcomes
Primary Outcomes
Lesion location
Time Frame: Between prostate biopsy and curative treatment decision , usually 2 month
Both MRI and PET results will be compared. Lesion location will be defined as "left", "right", "apical", "basal", "midline".
Extraprostatic involvement
Time Frame: Between prostate biopsy and curative treatment decision , usually 2 month
Both MRI and PET results will be compared. Involvement will be stated as "exist" , "non-exist".
Lesion Size
Time Frame: Between prostate biopsy and curative treatment decision , usually 2 month
Both MRI and PET results will be compared, Lesion size will be stated in milimeters.
Local and distant metastasis
Time Frame: Between prostate biopsy and curative treatment decision , usually 2 month
Both MRI and PET results will be compared. Metastasis will be stated as "exist" , "non-exist".
Lymph node involvement
Time Frame: Between prostate biopsy and curative treatment decision , usually 2 month
Both MRI and PET results will be compared. Involvement will be stated as "exist", "non-exist".